Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amphetamine-Related Disorders | 2 | 2020 | 69 | 1.050 |
Why?
|
| Methamphetamine | 2 | 2020 | 166 | 0.960 |
Why?
|
| Mexico | 11 | 2022 | 298 | 0.770 |
Why?
|
| Substance-Related Disorders | 3 | 2020 | 830 | 0.720 |
Why?
|
| Risk-Taking | 2 | 2022 | 457 | 0.640 |
Why?
|
| Unsafe Sex | 2 | 2020 | 162 | 0.630 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 486 | 0.600 |
Why?
|
| Referral and Consultation | 1 | 2018 | 142 | 0.540 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2010 | 129 | 0.490 |
Why?
|
| Health Personnel | 1 | 2018 | 277 | 0.470 |
Why?
|
| Women | 1 | 2015 | 28 | 0.470 |
Why?
|
| Texas | 5 | 2023 | 457 | 0.460 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 158 | 0.450 |
Why?
|
| Quality of Health Care | 1 | 2015 | 161 | 0.420 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 180 | 0.410 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 166 | 0.410 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 706 | 0.390 |
Why?
|
| HIV Infections | 6 | 2022 | 2586 | 0.390 |
Why?
|
| Needle Sharing | 1 | 2010 | 11 | 0.330 |
Why?
|
| Syphilis | 1 | 2010 | 24 | 0.320 |
Why?
|
| Sexual Behavior | 3 | 2022 | 638 | 0.290 |
Why?
|
| Adult | 12 | 2023 | 13872 | 0.280 |
Why?
|
| Young Adult | 6 | 2023 | 5080 | 0.260 |
Why?
|
| Male | 13 | 2023 | 23409 | 0.260 |
Why?
|
| Information Dissemination | 1 | 2007 | 66 | 0.260 |
Why?
|
| Decision Making | 1 | 2009 | 249 | 0.250 |
Why?
|
| Female | 13 | 2023 | 24698 | 0.250 |
Why?
|
| Humans | 17 | 2023 | 43102 | 0.230 |
Why?
|
| Qualitative Research | 2 | 2018 | 574 | 0.210 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 38 | 0.200 |
Why?
|
| Thrombosis | 1 | 2004 | 81 | 0.200 |
Why?
|
| Middle Aged | 6 | 2023 | 12222 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 367 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 3156 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 989 | 0.170 |
Why?
|
| Adolescent | 5 | 2023 | 6081 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2020 | 760 | 0.150 |
Why?
|
| Gender Identity | 1 | 2020 | 117 | 0.150 |
Why?
|
| Logistic Models | 3 | 2010 | 1009 | 0.140 |
Why?
|
| Cultural Competency | 1 | 2018 | 138 | 0.130 |
Why?
|
| Interviews as Topic | 2 | 2009 | 452 | 0.130 |
Why?
|
| Universities | 1 | 2020 | 559 | 0.120 |
Why?
|
| Lead Poisoning | 1 | 2016 | 25 | 0.120 |
Why?
|
| Sex Factors | 2 | 2017 | 1028 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 1723 | 0.120 |
Why?
|
| Human Rights | 1 | 2015 | 11 | 0.120 |
Why?
|
| Lead | 1 | 2016 | 100 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2018 | 352 | 0.110 |
Why?
|
| Age Factors | 1 | 2017 | 1154 | 0.110 |
Why?
|
| Health Surveys | 1 | 2015 | 405 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1234 | 0.100 |
Why?
|
| Social Support | 1 | 2015 | 445 | 0.090 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2010 | 7 | 0.080 |
Why?
|
| United States | 3 | 2010 | 5205 | 0.080 |
Why?
|
| AIDS Serodiagnosis | 1 | 2010 | 25 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 2009 | 3 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 160 | 0.070 |
Why?
|
| Blood Donors | 1 | 2009 | 20 | 0.070 |
Why?
|
| Sex Offenses | 1 | 2009 | 45 | 0.070 |
Why?
|
| Condoms | 1 | 2010 | 150 | 0.070 |
Why?
|
| California | 2 | 2008 | 548 | 0.070 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 1 | 0.070 |
Why?
|
| Luteolytic Agents | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cloprostenol | 1 | 2007 | 3 | 0.070 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2007 | 8 | 0.070 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2007 | 10 | 0.070 |
Why?
|
| Misoprostol | 1 | 2007 | 27 | 0.070 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2008 | 174 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2022 | 490 | 0.060 |
Why?
|
| Social Class | 1 | 2007 | 291 | 0.060 |
Why?
|
| Fibrinopeptide B | 1 | 2004 | 1 | 0.050 |
Why?
|
| Risk Factors | 2 | 2010 | 3994 | 0.050 |
Why?
|
| Ancrod | 1 | 2004 | 4 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2004 | 24 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2004 | 20 | 0.050 |
Why?
|
| Heparin | 1 | 2004 | 40 | 0.050 |
Why?
|
| Dogs | 1 | 2004 | 204 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2004 | 122 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2022 | 55 | 0.050 |
Why?
|
| Child | 1 | 2009 | 3443 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2022 | 392 | 0.030 |
Why?
|
| Cooking and Eating Utensils | 1 | 2016 | 1 | 0.030 |
Why?
|
| Ceramics | 1 | 2016 | 6 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2016 | 23 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2022 | 719 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 256 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 373 | 0.020 |
Why?
|
| History, 16th Century | 1 | 2008 | 4 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2008 | 24 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2007 | 8 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 15 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 67 | 0.020 |
Why?
|
| Urban Health | 1 | 2008 | 101 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2009 | 139 | 0.020 |
Why?
|
| Developing Countries | 1 | 2007 | 113 | 0.020 |
Why?
|
| Animals | 1 | 2004 | 16992 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 165 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 1612 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 1604 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 1772 | 0.010 |
Why?
|